Healthcare -
Biotechnology - NASDAQ - US
$ 0.5401
-1.85 %
$ 56.1 M
Market Cap
-1.17
P/E
UNCY - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities UNCY - Unicycive Therapeutics, Inc.
27.5 M
LAST VALUE
10.95%
2 YEAR CAGR
102.94%
5 YEAR CAGR
0.00%
10 YEAR CAGR